logo
Think You Understand Your Dog? Think Again.

Think You Understand Your Dog? Think Again.

New York Times10-03-2025

Dogs can't talk, but their body language speaks volumes. Many dogs will bow when they want to play, for instance, or lick their lips and avert their gaze when nervous or afraid.
But people aren't always good at interpreting such cues — or even noticing them, a new study suggests.
In the study, the researchers presented people with videos of a dog reacting to positive and negative stimuli, including a leash, a treat, a vacuum cleaner and a scolding. When asked to assess the dog's emotions, viewers seemed to pay more attention to the situational cues than the dog's actual behavior, even when the videos had been edited to be deliberately misleading. (In one video, for instance, a dog that appeared to be reacting to the sight of his leash had actually been shown a vacuum cleaner by his owner.)
'When it comes to just perceiving dog emotions, we think we know what's happening, but we're actually subconsciously relying on a lot of other factors,' said Holly Molinaro, who is a doctoral student at Arizona State University and the first author of the new paper, which was published on Monday in the journal Anthrozoös.
That bias could mislead owners about their dogs' well-being, Ms. Molinaro said. People who want to be attentive to their dog's experiences and emotions need to 'take a second or two to actually focus on the dog rather than everything else that's going on,' she said.
The idea for the study was born in 2021, when Ms. Molinaro was just beginning her doctoral work in canine emotions but the Covid-19 pandemic had sharply limited her ability to do in-person research.
She was inspired by studies that explore how context clues affect people's perceptions of others' emotions. She was also inspired by a distinctly pandemic-era technology: Zoom. The video conferencing software has a feature that blurs out workers' backgrounds. Ms Molinaro and her adviser, Clive Wynne — a canine-behavior expert at Arizona State — began to wonder if they could do something similar, creating videos that allowed people to see a dog's behavior without seeing what was unfolding around it.
And so, while visiting her parents in Connecticut, Ms. Molinaro began recording videos of her family dog, Oliver, a 14-year-old pointer-beagle mix, interacting with her father. In some of the videos, Ms. Molinaro's father did things that Oliver was likely to respond to positively, such as show him his leash or a toy. In others, he did things that were likely to elicit more negative reactions, such as gently scold Oliver or present him with Ms. Molinaro's cat, Saffron. ('He was not a fan,' she said.)
Then, after a crash course in video editing, Ms. Molinaro made versions of each video that removed all of the situational context, leaving footage of Oliver, alone, on a black background.
The researchers asked hundreds of undergraduates to watch both sets of videos and assess Oliver's emotional state in each clip. When the subjects evaluated the original videos, they rated Oliver's emotions as more positive in the positive scenarios than in the negative ones. But when the context was removed, they rated Oliver's emotions as equally positive in both types of situations.
Then, the scientists took things a step further by splicing together footage from different situations — showing, for instance, Ms. Molinaro's father presenting a vacuum alongside footage of Oliver's response to seeing his leash.
Viewers seemed to be swayed more by the context than by Oliver's behavior. When Ms. Molinaro's father was depicted doing something positive, subjects judged Oliver's emotions to be positive, even if he had been filmed reacting to something negative.
'There's no evidence at all that people actually see the dog,' Dr. Wynne said. 'They seem to have a sort of a big blind spot around the dog himself.'
The study has limitations, including that it was based on the behavior of just a single dog. People might also perform better when asked to evaluate the emotions of their own dogs, Dr. Wynne said, and probably would have noticed signs of intense terror or trauma. (The scientists did not subject Oliver to any extremely negative experiences.)
Still, he hoped that the study would be a wake-up call for pet owners. 'I'm taking it to heart in my own life,' said Dr. Wynne, who recently adopted a retired racing greyhound.
'I'm making it a project to learn how she expresses herself,' he added. 'Because if I know what makes her happy and unhappy, well, then I can guide her life toward greater happiness.'
Sadly, Oliver did not live long enough to see the study published. 'But it's sweet that he's memorialized in this research,' Ms. Molinaro said.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

What to know about the new ‘Nimbus' COVID variant
What to know about the new ‘Nimbus' COVID variant

Yahoo

time4 hours ago

  • Yahoo

What to know about the new ‘Nimbus' COVID variant

The World Health Organization (WHO) is keeping an eye on a new COVID-19 variant called NB.1.8.1, or 'Nimbus,' that has spread across Europe, the Americas and the Western Pacific. Nimbus is a descendant of the Omicron variant of the virus and was first identified in late January. Its spike mutations appear to make it more transmissible than other COVID-19 variants, according to the WHO. Spike mutations refer to changes in spike proteins, which sit on the surface of the virus and help it enter healthy cells. While it is spreading in the U.S. and Canada, along with 20 other countries, it does not appear to be driving an increase in sickness or hospitalization. In April, NB.1.8.1 sequences made up 10.7 percent of all submitted sequences from confirmed COVID infections, up from 2.5 percent a month earlier, according to a risk evaluation released by the WHO. The WHO last month deemed NB.1.8.1 a variant 'under monitoring.' Here's what to know about the variant. Most cases of COVID-19 in the U.S. still stem from the LP.8.1 strain, another Omicron descendant. But it looks like NB.1.8.1 might soon replace it as the more common strain, according to data from the Centers for Disease Control and Prevention (CDC). The CDC estimates that 37 percent of COVID-19 cases in the U.S. stem from the NB.1.8.1 variant, while 38 percent are a result from an infection of the LP.8.1 strain of the disease. At the end of May, the agency estimated the NB.1.8.1 variant caused about 15 percent of all COVID-19 cases. But the agency notes on its website that due to low numbers of virus sequences being reported, precision in the most recent reporting period is low. The NB.1.8.1 variant has been found in at least 13 states, according to Today, which cited data from the Global Initiative on Sharing All Influenza Data (GISAID) database. Those states are: California, New York, New Jersey, Maryland, Arizona, Illinois, Hawaii, Massachusetts, Ohio, Rhode Island, Vermont, Virginia and Washington. The available data on 'Nimbus' suggests it poses a low global threat and that existing COVID-19 vaccines provide adequate protection against severe illness and hospitalization, according to the WHO. 'Currently approved COVID-19 vaccines are expected to remain effective to this variant against symptomatic and severe disease,' the WHO's risk evaluation reads. 'Despite a concurrent increase in cases and hospitalizations in some countries where NB.1.8.1 is widespread, current data do not indicate that this variant leads to more severe illness than other variants in circulation.' Lionel Gresh, an international consultant at the WHO, told The Hill that many new cases in Canada are likely linked to the NB.1.8.1 variant, but that there has not been any major changes in the country in terms of cases, hospitalizations, ICU admissions or deaths linked to COVID-19. Symptoms of NB.1.8.1 seem to be similar to those associated with other Omicron variants, according to Gresh. Some common COVID-19 symptoms include cough, fever, fatigue, muscle aches, congestion, headache, nausea, vomiting, and a new loss of smell or taste, according to the CDC. 'We should be as concerned about [NB.1.8.1] as we are concerned for COVID in general,' Gresh said. 'Not more, not less.' Some recent COVID-19 patients have reported experiencing something called 'razor blade throat,' according to Salon. But it is unclear if that symptom is connected to one of the COVID variants or another respiratory illness circulating, Ryan Gregory, an evolutionary and genome biologist at the University of Guelph in Canada, told Salon. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

What to know about the new ‘Nimbus' COVID variant
What to know about the new ‘Nimbus' COVID variant

The Hill

time7 hours ago

  • The Hill

What to know about the new ‘Nimbus' COVID variant

The World Health Organization is keeping an eye on a new COVID-19 variant called NB.1.8.1, or 'Nimbus,' that has spread across Europe, the Americas and the Western Pacific. Nimbus is a descendant of the Omicron variant of the virus and was first identified in late January. Its spike mutations appear to make it more transmissible than other COVID variants, according to the WHO. Spike mutations refer to changes in spike proteins, which sit on the surface of the virus and help it enter healthy cells. While it is spreading in the U.S. and Canada, along with 20 other countries, it does not appear to be driving an increase in sickness or hospitalization. In April, NB.1.8.1 sequences made up 10.7 percent of all submitted sequences from confirmed COVID infections, up from 2.5 percent a month earlier, according to a risk evaluation released by the WHO. The WHO last month deemed NB.1.8.1 a variant 'under monitoring.' Here's what to know about the variant. Most cases of COVID-19 in the U.S. still stem from the LP.8.1 strain, another Omicron descendant. But it looks like NB.1.8.1 might soon replace it as the more common strain, according to data from the Centers for Disease Control and Prevention (CDC). The CDC estimates that 37 percent of COVID-19 cases in the U.S. stem from the NB.1.8.1 variant while 38 percent are a result from an infection of the LP.8.1 strain of the disease. At the end of May, the agency estimated that the NB.1.8.1 variant caused about 15 percent of all COVID cases. But the agency notes on its website that due to low numbers of virus sequences being reported, precision in the most recent reporting period is low. The NB.1.8.1 variant has been found in at least 13 states, according to Today, which cited data from the Global Initiative on Sharing All Influenza Data (GISAID) database. Those states are: California, New York, New Jersey, Maryland, Arizona, Illinois, Hawaii, Massachusetts, Ohio, Rhode Island, Vermont, Virginia and Washington. The available data on 'Nimbus' suggests that it poses a low global threat and that existing COVID-19 vaccines provide adequate protection against severe illness and hospitalization, according to the WHO. 'Currently approved COVID-19 vaccines are expected to remain effective to this variant against symptomatic and severe disease,' reads the WHO's risk evaluation. 'Despite a concurrent increase in cases and hospitalizations in some countries where NB.1.8.1 is widespread, current data do not indicate that this variant leads to more severe illness than other variants in circulation.' Lionel Gesh, an international consultant at the WHO, told The Hill that many new cases in Canada are likely linked to the NB.1.8.1 variant, but that there has not been any major changes in the country in terms of cases, hospitalizations, ICU admissions or deaths linked to COVID-19. Symptoms of NB.1.8.1 seem to be similar to those associated with other Omicron variants, according to Gresh. Some common COVID-19 symptoms include cough, fever, fatigue, muscle aches, congestion, headache, nausea, vomiting, and a new loss of smell or taste, according to the CDC. 'We should be as concerned about [NB.1.8.1] as we are concerned for COVID in general,' Gesh said. 'Not more, not less.' Some recent COVID-19 patients have reported experiencing something called 'razor blade throat,' according to Salon. But it is unclear if that symptom is connected to one of the COVID variants or another respiratory illness circulating, Ryan Gregory, an evolutionary and genome biologist at the University of Guelph in Canada, told the outlet.

Still Not Feeling the Same After COVID-19? You're Not Alone
Still Not Feeling the Same After COVID-19? You're Not Alone

Yahoo

time10 hours ago

  • Yahoo

Still Not Feeling the Same After COVID-19? You're Not Alone

Credit - Getty Images Most people have put the COVID-19 pandemic behind them. Infections, vaccinations, or a combination of both have bolstered people's immunity, and while new variants continue to pop up, getting sick does not induce the same panic it once did. But a new study shows that recovery from COVID-19 might not be as quick or straightforward as most of us now expect. The study, published in Open Forum Infectious Diseases, found that on average, it takes many people up to three months to return to good physical health after a COVID-19 infection, and nine months to recover good mental well-being. For up to 20% of infected people who were analyzed in the study, this mental-health recovery took even longer: up to a year or more. Lauren Wisk, assistant professor in the division of general internal medicine and health services research at the David Geffen School of Medicine at University of California, Los Angeles, and her team looked at data from people who had COVID-19 at eight health facilities across the U.S. from Dec. 2020 to Aug. 2022. People were asked to fill out surveys every three months for one year about their recovery, recording physical and mental symptoms like anxiety, depression, fatigue, social participation, sleep disturbances, and pain. It took people far longer to regain their mental well-being than it did their physical health. 'To be totally honest, we didn't necessarily expect to see different recovery trajectories as big as the ones we are seeing,' says Wisk. 'While it makes sense that some people recover faster physically, and other people recover faster mentally, on average the difference that we saw was surprising.' Read More: You Could Have Long COVID and Not Even Know It Wisk and her team also asked people to self-report if they experienced Long COVID, meaning symptoms stemming from their infection that lingered for at least three months. Nearly half of people who reported both poor physical and mental qualify of life following their infections also believed they had Long COVID. While the assessment was subjective, it tracked with the data Wisk's team collected; among people who reported just poor physical health, poor mental health, or neither, there were fewer reports of Long COVID. The findings point to the need for a deeper understanding of how COVID-19 infections affect the body, physically and mentally, in the short and long term, says Wisk. 'We need to be thinking about a longer road to recovery for people, because even if someone recovers physically from their symptoms, it might not end there for them.' Appreciating these longer lasting effects could help people seek treatment for their symptoms, which may condense their recovery period. Wisk says that short courses of anxiety medications and sleep therapies, for example, could address some of the lingering effects of COVID-19. 'We know how to treat the initial infection and how to keep people alive, but we don't have a great treatment protocol for the after effects and the lingering symptoms,' says Wisk. 'These data should help to guide development of protocols in which we think of recovery over a potentially long time horizon before people get back to normal.' Contact us at letters@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store